Castle Biosciences (CSTL) Cash from Financing Activities (2018 - 2026)
Castle Biosciences (CSTL) posted Cash from Financing Activities of -$5.0 million for Q1 2026, down 9.68% sequentially from -$4.6 million in Q4 2025, and down 224.08% YoY from $4.1 million in Q1 2025.
Castle Biosciences (CSTL) Cash from Financing Activities (2018 - 2026) Analysis & Trends
Castle Biosciences (CSTL) has 9 years of Cash from Financing Activities data on file, last reported at -$5.0 million in Q1 2026.
- Quarterly Cash from Financing Activities fell 224.08% year-over-year to -$5.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$10.4 million (down 72.33% YoY) and the FY2025 annual result came in at -$7.0 million, down 213.37% from the prior year.
- Cash from Financing Activities slipped to -$5.0 million in Q1 2026 per CSTL's latest filing, from -$4.6 million in the prior quarter.
- The five-year high for Cash from Financing Activities was $10.6 million in Q1 2024, with the low at -$5.4 million in Q4 2024.
- Average Cash from Financing Activities over 5 years is -$390411.8, with a median of $45000.0 recorded in 2023.
- Year-over-year, Cash from Financing Activities sank 695.24% in 2022 and jumped 1762.22% in 2024.
- Castle Biosciences' Cash from Financing Activities stood at -$750000.0 in 2022, then slumped by 339.6% to -$3.3 million in 2023, then tumbled by 63.33% to -$5.4 million in 2024, then climbed by 14.78% to -$4.6 million in 2025, then decreased by 9.68% to -$5.0 million in 2026.
- Business Quant data shows CSTL's Cash from Financing Activities at -$5.0 million in Q1 2026, -$4.6 million in Q4 2025, and -$919000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -213.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 1.09 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 46.00 Mn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | -211.43 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 3.76 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | -144.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | -433.00 Mn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | -251.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | -114.33 Mn |
| 10 | Castle Biosciences | 738.56 Mn | 476.84 Mn | 63.15 Mn | -5.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.03 Mn |
| Mar 31, 2026 | -5.03 Mn |
| Dec 31, 2025 | -4.59 Mn |
| Dec 31, 2025 | -4.59 Mn |
| Sep 30, 2025 | -919,000.00 |
| Sep 30, 2025 | -919,000.00 |
| Jun 30, 2025 | 101,000.00 |
| Jun 30, 2025 | 101,000.00 |
| Mar 31, 2025 | -1.55 Mn |
| Mar 31, 2025 | -1.55 Mn |
| Dec 31, 2024 | -5.39 Mn |
| Dec 31, 2024 | -5.39 Mn |
| Sep 30, 2024 | 838,000.00 |
| Sep 30, 2024 | 838,000.00 |
| Jun 30, 2024 | 42,000.00 |
| Jun 30, 2024 | 42,000.00 |
| Mar 31, 2024 | 10.64 Mn |
| Mar 31, 2024 | 10.64 Mn |
| Dec 31, 2023 | -3.30 Mn |
| Dec 31, 2023 | -3.30 Mn |